BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25963978)

  • 1. Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer.
    Xu W; Ying Y; Shan L; Feng J; Zhang S; Gao Y; Xu X; Yao Y; Zhu C; Mao W
    J Transl Med; 2015 May; 13():153. PubMed ID: 25963978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Cohesin Loading Factor Nipped-B-Like Protein (NIPBL) Induces Cell Cycle Arrest, Apoptosis, and Autophagy of Breast Cancer Cell Lines.
    Zhou H; Zheng L; Lu K; Gao Y; Guo L; Xu W; Wang X
    Med Sci Monit; 2017 Oct; 23():4817-4825. PubMed ID: 28987049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
    Zhao H; Xie YZ; Xing R; Sun M; Chi F; Zeng YC
    Cell Oncol (Dordr); 2017 Aug; 40(4):357-365. PubMed ID: 28567715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer.
    Zhang B; Wang J; Liu W; Yin Y; Qian D; Zhang H; Shi B; Li C; Zhu J; Zhang L; Gao L; Wang C
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2479-2487. PubMed ID: 27601168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
    Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
    Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
    Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major vault protein suppresses lung cancer cell proliferation by inhibiting STAT3 signaling pathway.
    Bai H; Wang C; Qi Y; Xu J; Li N; Chen L; Jiang B; Zhu X; Zhang H; Li X; Yang Q; Ma J; Xu Y; Ben J; Chen Q
    BMC Cancer; 2019 May; 19(1):454. PubMed ID: 31092229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer.
    Shen L; Yang M; Lin Q; Zhang Z; Miao C; Zhu B
    Oncol Rep; 2016 May; 35(5):2561-8. PubMed ID: 26985856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
    Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C
    Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.
    Sun S; Ke Z; Wang F; Li S; Chen W; Han A; Wang Z; Shi H; Wang LT; Chen X
    Hum Pathol; 2012 Jul; 43(7):1051-60. PubMed ID: 22204714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
    Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer.
    Lin SY; Chang HH; Lai YH; Lin CH; Chen MH; Chang GC; Tsai MF; Chen JJ
    PLoS One; 2015; 10(5):e0123305. PubMed ID: 25955608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
    Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
    Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
    Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer.
    Azuma Y; Yokobori T; Mogi A; Altan B; Yajima T; Kosaka T; Onozato R; Yamaki E; Asao T; Nishiyama M; Kuwano H
    J Surg Oncol; 2015 Aug; 112(2):231-7. PubMed ID: 26180037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.